[Skip to Navigation]
Article
June 1964

Vaccine Therapy In Recurrent Herpes Simplex

Author Affiliations

PROVIDENCE, RI; PAWTUCKET, RI

Assistant Clinical Professor of Dermatology, Boston University School of Medicine, Boston University Medical Center (Dr. Kern and Dr. Schiff).

Arch Dermatol. 1964;89(6):844-845. doi:10.1001/archderm.1964.01590300072021
Abstract

Prevention of recurrent herpes simplex, despite numerous recommended procedures, has remained a problem. In one of our previous studies, inoculation with a nonspecific vaccine gave results no better than those with the same vaccine which had been heatinactivated. It appeared possible that a specific vaccine might produce greater benefit. A double-blind study has recently been conducted in which one group of patients with recurrent herpes simplex received a series of injections of a specific herpes virus vaccine while the control group was given a placebo solution. No significant difference between the results in the two groups was obtained. It is concluded that the benefit observed is attributable to psychotherapeutic effects.

Add or change institution
×